AZD 9291

Pricing Availability   Qty

Save Up to 35% on Select RUO Reagents. See Details

说明: Potent mutant-selective EGFR inhibitor
化学名: N-[2-[[2-(Dimethylamino)ethyl]methylamino]-4-methoxy-5-[[4-(1-methyl-1H-indol-3-yl)-2-pyrimidinyl]amino]phenyl]-2-propenamide
纯度: ≥98% (HPLC)
说明书
引用文献
评论
文献 (1)

生物活性 for AZD 9291

AZD 9291 is a potent mutant-selective EGFR inhibitor (IC50 values are 1 and 12 nM against EGFR mutants L858R/T790M and L858R, respectively). AZD 9291 exhibited nearly 200 times greater potency against L858R/T790M than wild-type EGFR. In vivo, AZD 9291 causes tumor regression in mutant EGFR xenograft models of non-small cell lung cancer (NSCLC) and transgenic mutant T790M EGFR disease models. AZD 9291 is orally bioavailable.

技术数据 for AZD 9291

分子量 499.61
公式 C28H33N7O2
储存 Store at -20°C
纯度 ≥98% (HPLC)
CAS Number 1421373-65-0
PubChem ID 71496458
InChI Key DUYJMQONPNNFPI-UHFFFAOYSA-N
Smiles O=C(C=C)NC1=CC(NC=2N=CC=C(N2)C3=CN(C=4C=CC=CC34)C)=C(OC)C=C1N(C)CCN(C)C

上方提供的技术数据仅供参考。批次相关数据请参见分析证书。

Tocris products are intended for laboratory research use only, unless stated otherwise.

溶解性数据 for AZD 9291

溶剂 最高浓度 mg/mL 最高浓度 mM
溶解性
DMSO 24.98 50
ethanol 9.99 20

制备储备液 for AZD 9291

以下数据基于产品分子量 499.61。 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

选择批次从而根据批次分子量重新计算:
浓度/溶剂体积/质量 1 mg 5 mg 10 mg
0.5 mM 4 mL 20.02 mL 40.03 mL
2.5 mM 0.8 mL 4 mL 8.01 mL
5 mM 0.4 mL 2 mL 4 mL
25 mM 0.08 mL 0.4 mL 0.8 mL

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.
=
x
x
g/mol

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Dilution Calculator

Calculate the dilution required to prepare a stock solution.
x
=
x

参考文献 for AZD 9291

参考文献是支持产品生物活性的出版物。

Cross et al (2014) AZD9291, an irreversible EGFR TKI, overcomes T790M-mediated resistance to EGFR inhibitors in lung cancer. Cancer Discov. 4 1046 PMID: 24893891


If you know of a relevant reference for AZD 9291, please let us know.

按产品操作查看相关产品

查看全部 EGFR Inhibitors

关键词: AZD 9291, AZD 9291 supplier, AZD9291, AZD-9291, osimertinib, potent, mutant-selective, EGFR, epidermal, growth, factor, receptor, tyrosine, kinase, inhibitors, inhibits, lung, cancer, T790M, L858R, non-small, cell, nsclc, orally, bioavailable, 8873, Tocris Bioscience

篇 AZD 9291 的引用文献

引用文献是使用了 Tocris 产品的出版物。

目前没有 AZD 9291 的引用文献。 您是否知道使用了 Tocris AZD 9291 的优秀论文? 请告知我们.

AZD 9291 的评论

目前没有该产品的评论。 Be the first to review AZD 9291 and earn rewards!

Have you used AZD 9291?

Submit a review and receive an Amazon gift card.

$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image

$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image

Submit a Review

该领域的文献

Tocris offers the following scientific literature in this area to showcase our products. We invite you to request* your copy today!

*请注意,Tocris 仅会向正规科研企业/机构地址发送文献。


Angiogenesis in Cancer Poster

Angiogenesis in Cancer Poster

This poster summarizes the pathogenesis of angiogenesis in cancer, as well as some of the main angiogenesis therapeutic targets.